Octagon Capital Advisors LP Quant / Systematic

Location: New York, NY

CIK: 0001839435 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 16, 2022

Total Value: $463M (100.0% shares, 0.0% debt)

Holdings (24)

APLS APELLIS PHARMACEUTICALS INC 25.7%
Value $119M Shares 2,340,059 Est. Cost $46.85 Unrealized -5.8%
RCUS ARCUS BIOSCIENCES INC 17.0%
Value $78.58M Shares 2,489,974 Est. Cost $33.91 Unrealized -1.2%
CLDX CELLDEX THERAPEUTICS INC NEW 5.6%
Value $25.93M Shares 761,398 Est. Cost $25.60 Unrealized +24.9%
FDMT 4D MOLECULAR THERAPEUTICS IN 5.1%
Value $23.69M Shares 1,566,895 Est. Cost $30.23 Unrealized -48.1%
BBIO BRIDGEBIO PHARMA INC 5.0%
Value $23.02M Shares 2,267,486 Est. Cost $38.67 Unrealized -73.5%
GOSS GOSSAMER BIO INC 4.8%
Value $22.25M Shares 2,563,138 Est. Cost $9.74 Unrealized -1.0%
CHINOOK THERAPEUTICS INC 4.8%
Value $22.19M Shares 1,356,250 Est. Cost $16.34 Unrealized
KROS KEROS THERAPEUTICS INC 4.0%
Value $18.5M Shares 340,214 Est. Cost $49.87 Unrealized +2.9%
STOK STOKE THERAPEUTICS INC 3.7%
Value $17.12M Shares 813,456 Est. Cost $27.91 Unrealized -28.3%
NBP I MAB 3.7%
Value $17.05M Shares 1,049,691 Est. Cost $59.03 Unrealized
ITEOS THERAPEUTICS INC 3.1%
Value $14.51M Shares 450,776 Est. Cost $46.56 Unrealized
VERA VERA THERAPEUTICS INC 2.9%
Value $13.51M Shares 575,000 Est. Cost $15.54 Unrealized +38.5%
ARVN ARVINAS INC 2.6%
Value $12.01M Shares 178,500 Est. Cost $37.11 Unrealized +83.7%
HORIZON THERAPEUTICS PUB L 2.3%
Value $10.52M Shares 100,000 Est. Cost $105.21 Unrealized
IPSC CENTURY THERAPEUTICS INC 1.8%
Value $8.288M Shares 658,266 Est. Cost $24.92 Unrealized -46.8%
IMVT IMMUNOVANT INC 1.8%
Value $8.127M Shares 1,475,000 Est. Cost $7.02 Unrealized -11.2%
SURFACE ONCOLOGY INC 1.5%
Value $6.762M Shares 2,300,000 Est. Cost $2.94 Unrealized
RNAM AVIDITY BIOSCIENCES INC 1.3%
Value $5.941M Shares 321,641 Est. Cost $28.99 Unrealized -41.4%
DYN DYNE THERAPEUTICS INC 1.1%
Value $5.064M Shares 525,284 Est. Cost $19.71 Unrealized -56.8%
XBI SPDR SER TR 1.1%
Value $5.015M Shares 55,800 Est. Cost $89.87 Unrealized
PROMETHEUS BIOSCIENCES INC 0.7%
Value $3.021M Shares 80,000 Est. Cost $18.26 Unrealized
OMEGA THERAPEUTICS INC 0.2%
Value $1.101M Shares 176,470 Est. Cost $18.85 Unrealized
CONNECT BIOPHARMA HLDGS LTD 0.2%
Value $845K Shares 279,921 Est. Cost $18.50 Unrealized
AMBRX BIOPHARMA INC 0.1%
Value $616K Shares 149,400 Est. Cost $19.60 Unrealized